Rigel Pharmaceuticals Inc (NASDAQ: RIGL) stock closed at $30.28 on 9/24/25 after a major decline of -11.0%. Moreover, unusually high trading volume at 164% of normal accompanied the decline. The stock has declined -13.4% during the last week but has been exceptionally strong relative to the market over the last nine months.
Current PriceTarget Research Rating
Rigel Pharmaceuticals has a current Value Trend Rating of A (Highest Rating). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing highly consistent signals. Rigel Pharmaceuticals has a very high Power Rating of 91 and a very high Appreciation Score of 99, triggering the Highest Value Trend Rating.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of A. This review will be completed in the next several days.
Be the first to comment